ENDOCHOICE HOLDINGS, INC. Research and Development Expense
ENDOCHOICE HOLDINGS, INC. reported Research and Development Expense of $4.42 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-11-07
- ENDOCHOICE HOLDINGS, INC. research and development expense for the quarter ending 2016-09-30 was $4.42M, a 12.24% increase year-over-year.
- ENDOCHOICE HOLDINGS, INC. research and development expense for the quarter ending 2016-06-30 was $4.97M, a 3.77% decline year-over-year.
- ENDOCHOICE HOLDINGS, INC. research and development expense for the quarter ending 2016-03-31 was $4.02M, a 14.09% decline year-over-year.
- ENDOCHOICE HOLDINGS, INC. research and development expense for the quarter ending 2015-12-31 was $3.50M, a 28.24% decline year-over-year.
- ENDOCHOICE HOLDINGS, INC. research and development expense for fiscal 2015 was $17.29M, a 20.34% decline from fiscal 2014.
- ENDOCHOICE HOLDINGS, INC. research and development expense for fiscal 2014 was $21.70M, a 30.60% increase from fiscal 2013.
- ENDOCHOICE HOLDINGS, INC. research and development expense for fiscal 2013 was $16.62M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2016-09-30 | $4.42M 10-Q · filed 2016-11-07 | $9.39M derived: sum of 2 quarters · filed 2016-11-07 | $13.41M 10-Q · filed 2016-11-07 | $16.91M derived: sum of 4 quarters · filed 2016-11-07 |
| 2016-06-30 | $4.97M 10-Q · filed 2016-08-03 | $8.99M 10-Q · filed 2016-08-03 | $12.49M derived: sum of 3 quarters · filed 2016-08-03 | $16.43M derived: sum of 4 quarters · filed 2016-11-07 |
| 2016-03-31 | $4.02M 10-Q · filed 2016-05-04 | $7.52M derived: sum of 2 quarters · filed 2016-05-04 | $11.46M derived: sum of 3 quarters · filed 2016-11-07 | $16.63M derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $7.44M derived: sum of 2 quarters · filed 2016-11-07 | $12.61M derived: sum of 3 quarters · filed 2016-11-07 | $17.29M 10-K · filed 2016-03-21 |
| 2015-09-30 | $3.94M 10-Q · filed 2016-11-07 | $9.10M derived: sum of 2 quarters · filed 2016-11-07 | $13.79M 10-Q · filed 2016-11-07 | $18.67M derived: sum of 4 quarters · filed 2016-11-07 |
| 2015-06-30 | $5.17M 10-Q · filed 2016-08-03 | $9.85M 10-Q · filed 2016-08-03 | $14.73M derived: sum of 3 quarters · filed 2016-08-03 | $20.48M derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-03-31 | $4.68M 10-Q · filed 2016-05-04 | $9.56M derived: sum of 2 quarters · filed 2016-05-04 | $15.31M derived: sum of 3 quarters · filed 2016-05-04 | $21.23M derived: sum of 4 quarters · filed 2016-05-04 |
| 2014-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $10.63M derived: sum of 2 quarters · filed 2016-03-21 | $16.55M derived: sum of 3 quarters · filed 2016-03-21 | $21.70M 10-K · filed 2016-03-21 |
| 2014-09-30 | $5.75M 10-Q · filed 2015-11-05 | $11.67M derived: sum of 2 quarters · filed 2015-11-05 | $16.82M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $5.92M 10-Q · filed 2015-08-06 | $11.07M 10-Q · filed 2015-08-06 | ||
| 2013-12-31 | $16.62M 10-K · filed 2016-03-21 |